MicroCME 2022

MicroCME modules are 15 to 30 minute courses that will offer CME designed to fit busy schedules.

The MicroCME project helps close gaps in busy clinicians’ knowledge and practice by providing a curated selection of the “best of the best”, most relevant and compelling individual presentations from the ACAAI annual meeting. These curated presentations help clinicians to stay up to date with the latest research and strategies in the field. 

Courses Included:

  • Is the Basophil Activation Test Ready for Primetime? 
  • Addressing Unproven Diagnostic Testing 
  • Pediatric Asthma 
  • Immunology of Sleep 
  • NIH Asthma Guidelines 
  • Targeted Therapies for Specific Asthma Phenotypes 
  • Economic Outlook for Biologics in Asthma - Are They Cost-Effective? 
  • What Have We Gleaned from Our Experiences with Currently Approved Biologics? 
  • Generalized Dermatitis 
  • What's New: Update in Pediatric Dermatology 
  • Treatment Approaches for Difficult to Control Urticaria 
  • Climate Change, Allergic Disease 
  • Rules of OIT - Patient Illness, Vacations, Exercise, and More 
  • More than Peanut - Expanding Your OIT Program to Include Other Foods 
  • Allergens and Standardization 
  • SLIT Basics for the Allergist 
  • Pediatric Epidemiology 
  • Malignancy and B-cell Depleting Agents 
  • Pediatric Biologics 
  • Pediatric Immunology 
  • Pediatric Food Allergy Treatment 
  • The FPIES Patient - Diagnosis & Management Approaches 
  • Hypersensitivity to beta-lactams and NSAIDs 
  • Adverse Reactions to Biologics and Chemotherapy 
  • Psychology Interventions in Patients with Depression or Anxiety for Allergists 
  • Surgical Management of Nasal Polyps 
  • Are Biologics a Game Changer for the Management of Patients with AERD? 

 

Learning Objectives

By participating in these podcasts, learners should be able to:

  • Provide physicians with the latest research in the field of allergy/immunology relevant to practice.
  • Provide physicians with tools and techniques to implement the latest therapy recommendations.
  • Provide physicians with the tools they need to monitor their practice and assess the implementation of therapy recommendations.
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. The ACCME defines a “commercial interest” as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity.

Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

  • Stanley Fineman, MD

Independent contractor/contracted research: Aimmune, DVB Technologies, BioCryst, Regeneron; Speaker/honorarium: Boehringer-Ingelheim, Takeda/Shire

  • Merin Kalangara (Kuruvilla), MD
  • Gerald Lee, MD
Course summary
Course opens: 
05/01/2022
Course expires: 
12/31/2023
Rating: 
0

The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Please login or create an account to take this course.